Flerie AB (publ) (STO: FLERIE)
Sweden
· Delayed Price · Currency is SEK 45.11
+0.62 (1.38%)
Nov 18, 2024, 5:29 PM CET
Flerie AB Company Description
Flerie AB (publ) is a venture capital firm specializing in early-stage investments.
It seeks to invest in biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time.
The firm seeks to invest in Europe, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.
Flerie AB (publ)
| Country | Sweden |
| Founded | 2011 |
| Industry | Pharmaceutical Preparations |
| CEO | Ted Fjallman |
Contact Details
Address: Skeppsbron 16 Stockholm, 111 30 Sweden | |
| Phone | 46 (0)76 131 01 27 |
| Website | flerie.com |
Stock Details
| Ticker Symbol | FLERIE |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0008966295 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ted Fjallman | Chief Executive Officer |
| Cecilia Schéele | Chief Financial Officer |